APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Serialisation Services

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmaceutical Serialisation Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

12 August 2026199 pages

Choose your research edition.

Industry ResearchPharmaceutical Serialisation Services Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Serialisation Services Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Serialisation Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Serialisation Services Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Serialisation Services Market Analysis and Forecast 2026-2032186 pages · $4,950 USD

Market perspective

The global Pharmaceutical Serialisation Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pharmaceutical Serialisation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Serialisation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Serialisation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmaceutical Serialisation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmaceutical Serialisation Services include Movianto, UPM Pharmaceuticals, MSK Pharmalogisti, Covectra, Koerber-Pharma, Palladio Group, TraceLink, Ultimate Solutions and Clarkston Consulting, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pharmaceutical Serialisation Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Serialisation Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Serialisation Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharmaceutical Serialisation Services market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical Serialisation Services Segment by Company

Movianto

UPM Pharmaceuticals

MSK Pharmalogisti

Covectra

Koerber-Pharma

Palladio Group

TraceLink

Ultimate Solutions

Clarkston Consulting

Jones Healthcare Group

MSK Pharmalogistic

Vetter-Pharma

NextPharma Logistics

OPTEL

Central Pharma

Aphena Pharma +C581Solutions

NNE

Sharp Services

Pharmaceutical Serialisation Services Segment by Type

Barcode

QR Code

RFID

Others

Pharmaceutical Serialisation Services Segment by Application

Pharmaceutical Manufacturing

Pharmaceutical Distribution

Pharmaceutical Logistics

Pharmaceutical Serialisation Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Serialisation Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Serialisation Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Serialisation Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharmaceutical Serialisation Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Serialisation Services industry.

Chapter 3: Detailed analysis of Pharmaceutical Serialisation Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Serialisation Servicesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Serialisation Services Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Barcode Table 3. Key Players of QR Code Table 4. Key Players of RFID Table 3. Key Players of Others Table 4. Global Pharmaceutical Serialisation Services Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharmaceutical Manufacturing Table 6. Key Players of Pharmaceutical Distribution Table 7. Key Players of Pharmaceutical Logistics Table 8. Global Pharmaceutical Serialisation Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Pharmaceutical Serialisation Services Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Pharmaceutical Serialisation Services Market Share by Region (2021-2026) Table 11. Global Pharmaceutical Serialisation Services Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Pharmaceutical Serialisation Services Market Share by Region (2027-2032) Table 13. Pharmaceutical Serialisation Services Industry Trends Table 14. Pharmaceutical Serialisation Services Industry Drivers Table 15. Pharmaceutical Serialisation Services Industry Opportunities and Challenges Table 16. Pharmaceutical Serialisation Services Industry Restraints Table 17. Global Pharmaceutical Serialisation Services Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Pharmaceutical Serialisation Services Revenue Market Share by Company (2021-2026) Table 19. Global Pharmaceutical Serialisation Services Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pharmaceutical Serialisation Services Key Company Head Office and Area Served Table 21. Global Pharmaceutical Serialisation Services Company, Product Type & Application Table 22. Global Pharmaceutical Serialisation Services Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Pharmaceutical Serialisation Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Pharmaceutical Serialisation Services Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pharmaceutical Serialisation Services Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Pharmaceutical Serialisation Services Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Pharmaceutical Serialisation Services Revenue Market Share by Type (2021-2026) Table 29. Global Pharmaceutical Serialisation Services Revenue Market Share by Type (2027-2032) Table 30. Global Pharmaceutical Serialisation Services Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pharmaceutical Serialisation Services Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Pharmaceutical Serialisation Services Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Pharmaceutical Serialisation Services Revenue Market Share by Application (2021-2026) Table 34. Global Pharmaceutical Serialisation Services Revenue Market Share by Application (2027-2032) Table 35. Movianto Company Information Table 36. Movianto Business Overview Table 37. Movianto Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Movianto Pharmaceutical Serialisation Services Product Portfolio Table 39. Movianto Recent Development Table 40. UPM Pharmaceuticals Company Information Table 41. UPM Pharmaceuticals Business Overview Table 42. UPM Pharmaceuticals Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. UPM Pharmaceuticals Pharmaceutical Serialisation Services Product Portfolio Table 44. UPM Pharmaceuticals Recent Development Table 45. MSK Pharmalogisti Company Information Table 46. MSK Pharmalogisti Business Overview Table 47. MSK Pharmalogisti Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. MSK Pharmalogisti Pharmaceutical Serialisation Services Product Portfolio Table 49. MSK Pharmalogisti Recent Development Table 50. Covectra Company Information Table 51. Covectra Business Overview Table 52. Covectra Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Covectra Pharmaceutical Serialisation Services Product Portfolio Table 54. Covectra Recent Development Table 55. Koerber-Pharma Company Information Table 56. Koerber-Pharma Business Overview Table 57. Koerber-Pharma Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Koerber-Pharma Pharmaceutical Serialisation Services Product Portfolio Table 59. Koerber-Pharma Recent Development Table 60. Palladio Group Company Information Table 61. Palladio Group Business Overview Table 62. Palladio Group Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Palladio Group Pharmaceutical Serialisation Services Product Portfolio Table 64. Palladio Group Recent Development Table 65. TraceLink Company Information Table 66. TraceLink Business Overview Table 67. TraceLink Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. TraceLink Pharmaceutical Serialisation Services Product Portfolio Table 69. TraceLink Recent Development Table 70. Ultimate Solutions Company Information Table 71. Ultimate Solutions Business Overview Table 72. Ultimate Solutions Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Ultimate Solutions Pharmaceutical Serialisation Services Product Portfolio Table 74. Ultimate Solutions Recent Development Table 75. Clarkston Consulting Company Information Table 76. Clarkston Consulting Business Overview Table 77. Clarkston Consulting Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Clarkston Consulting Pharmaceutical Serialisation Services Product Portfolio Table 79. Clarkston Consulting Recent Development Table 80. Jones Healthcare Group Company Information Table 81. Jones Healthcare Group Business Overview Table 82. Jones Healthcare Group Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Jones Healthcare Group Pharmaceutical Serialisation Services Product Portfolio Table 84. Jones Healthcare Group Recent Development Table 85. MSK Pharmalogistic Company Information Table 86. MSK Pharmalogistic Business Overview Table 87. MSK Pharmalogistic Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. MSK Pharmalogistic Pharmaceutical Serialisation Services Product Portfolio Table 89. MSK Pharmalogistic Recent Development Table 90. Vetter-Pharma Company Information Table 91. Vetter-Pharma Business Overview Table 92. Vetter-Pharma Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Vetter-Pharma Pharmaceutical Serialisation Services Product Portfolio Table 94. Vetter-Pharma Recent Development Table 95. NextPharma Logistics Company Information Table 96. NextPharma Logistics Business Overview Table 97. NextPharma Logistics Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. NextPharma Logistics Pharmaceutical Serialisation Services Product Portfolio Table 99. NextPharma Logistics Recent Development Table 100. OPTEL Company Information Table 101. OPTEL Business Overview Table 102. OPTEL Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. OPTEL Pharmaceutical Serialisation Services Product Portfolio Table 104. OPTEL Recent Development Table 105. Central Pharma Company Information Table 106. Central Pharma Business Overview Table 107. Central Pharma Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Central Pharma Pharmaceutical Serialisation Services Product Portfolio Table 109. Central Pharma Recent Development Table 110. Aphena Pharma +C581Solutions Company Information Table 111. Aphena Pharma +C581Solutions Business Overview Table 112. Aphena Pharma +C581Solutions Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Aphena Pharma +C581Solutions Pharmaceutical Serialisation Services Product Portfolio Table 114. Aphena Pharma +C581Solutions Recent Development Table 115. NNE Company Information Table 116. NNE Business Overview Table 117. NNE Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. NNE Pharmaceutical Serialisation Services Product Portfolio Table 119. NNE Recent Development Table 120. Sharp Services Company Information Table 121. Sharp Services Business Overview Table 122. Sharp Services Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Sharp Services Pharmaceutical Serialisation Services Product Portfolio Table 124. Sharp Services Recent Development Table 125. North America Pharmaceutical Serialisation Services Market Size by Type (2021-2026) & (US$ Million) Table 126. North America Pharmaceutical Serialisation Services Market Size by Type (2027-2032) & (US$ Million) Table 127. North America Pharmaceutical Serialisation Services Market Size by Application (2021-2026) & (US$ Million) Table 128. North America Pharmaceutical Serialisation Services Market Size by Application (2027-2032) & (US$ Million) Table 129. North America Pharmaceutical Serialisation Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Pharmaceutical Serialisation Services Market Size by Country (2021-2026) Table 131. North America Pharmaceutical Serialisation Services Market Size by Country (2027-2032) Table 132. Europe Pharmaceutical Serialisation Services Market Size by Type (2021-2026) & (US$ Million) Table 133. Europe Pharmaceutical Serialisation Services Market Size by Type (2027-2032) & (US$ Million) Table 134. Europe Pharmaceutical Serialisation Services Market Size by Application (2021-2026) & (US$ Million) Table 135. Europe Pharmaceutical Serialisation Services Market Size by Application (2027-2032) & (US$ Million) Table 136. Europe Pharmaceutical Serialisation Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Pharmaceutical Serialisation Services Market Size by Country (2021-2026) Table 138. Europe Pharmaceutical Serialisation Services Market Size by Country (2027-2032) Table 139. China Pharmaceutical Serialisation Services Market Size by Type (2021-2026) & (US$ Million) Table 140. China Pharmaceutical Serialisation Services Market Size by Type (2027-2032) & (US$ Million) Table 141. China Pharmaceutical Serialisation Services Market Size by Application (2021-2026) & (US$ Million) Table 142. China Pharmaceutical Serialisation Services Market Size by Application (2027-2032) & (US$ Million) Table 143. Asia Pharmaceutical Serialisation Services Market Size by Type (2021-2026) & (US$ Million) Table 144. Asia Pharmaceutical Serialisation Services Market Size by Type (2027-2032) & (US$ Million) Table 145. Asia Pharmaceutical Serialisation Services Market Size by Application (2021-2026) & (US$ Million) Table 146. Asia Pharmaceutical Serialisation Services Market Size by Application (2027-2032) & (US$ Million) Table 147. Asia Pharmaceutical Serialisation Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Pharmaceutical Serialisation Services Market Size by Country (2021-2026) Table 149. Asia Pharmaceutical Serialisation Services Market Size by Country (2027-2032) Table 150. South America, Middle East & Africa Pharmaceutical Serialisation Services Market Size by Type (2021-2026) & (US$ Million) Table 151. South America, Middle East & Africa Pharmaceutical Serialisation Services Market Size by Type (2027-2032) & (US$ Million) Table 152. South America, Middle East & Africa Pharmaceutical Serialisation Services Market Size by Application (2021-2026) & (US$ Million) Table 153. South America, Middle East & Africa Pharmaceutical Serialisation Services Market Size by Application (2027-2032) & (US$ Million) Table 154. South America, Middle East & Africa Pharmaceutical Serialisation Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. South America, Middle East & Africa Pharmaceutical Serialisation Services Market Size by Country (2021-2026) Table 156. South America, Middle East & Africa Pharmaceutical Serialisation Services Market Size by Country (2027-2032) Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Pharmaceutical Serialisation Services Product Image Figure 2. Global Pharmaceutical Serialisation Services Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pharmaceutical Serialisation Services Market Share by Type: 2025 VS 2032 Figure 4. Barcode Image Figure 5. QR Code Image Figure 6. RFID Image Figure 7. Others Image Figure 8. Global Pharmaceutical Serialisation Services Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Pharmaceutical Serialisation Services Market Share by Application: 2025 VS 2032 Figure 10. Pharmaceutical Manufacturing Image Figure 11. Pharmaceutical Distribution Image Figure 12. Pharmaceutical Logistics Image Figure 13. Global Pharmaceutical Serialisation Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 15. Global Pharmaceutical Serialisation Services Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Pharmaceutical Serialisation Services Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Pharmaceutical Serialisation Services Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Pharmaceutical Serialisation Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pharmaceutical Serialisation Services Revenue Market Share by Type (2021-2032) Figure 22. Global Pharmaceutical Serialisation Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Pharmaceutical Serialisation Services Revenue Market Share by Application (2021-2032) Figure 24. North America Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 25. North America Pharmaceutical Serialisation Services Market Share by Type (2021-2032) Figure 26. North America Pharmaceutical Serialisation Services Market Share by Application (2021-2032) Figure 27. North America Pharmaceutical Serialisation Services Market Share by Country (2021-2032) Figure 28. United States Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 29. Canada Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 31. Europe Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 32. Europe Pharmaceutical Serialisation Services Market Share by Type (2021-2032) Figure 33. Europe Pharmaceutical Serialisation Services Market Share by Application (2021-2032) Figure 34. Europe Pharmaceutical Serialisation Services Market Share by Country (2021-2032) Figure 35. Germany Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 36. France Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 38. Italy Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 39. Russia Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 41. China Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 42. China Pharmaceutical Serialisation Services Market Share by Type (2021-2032) Figure 43. China Pharmaceutical Serialisation Services Market Share by Application (2021-2032) Figure 44. Asia Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 45. Asia Pharmaceutical Serialisation Services Market Share by Type (2021-2032) Figure 46. Asia Pharmaceutical Serialisation Services Market Share by Application (2021-2032) Figure 47. Asia Pharmaceutical Serialisation Services Market Share by Country (2021-2032) Figure 48. Japan Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 52. India Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 53. Australia Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Pharmaceutical Serialisation Services Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Pharmaceutical Serialisation Services Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Pharmaceutical Serialisation Services Market Share by Country (2021-2032) Figure 58. Brazil Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 63. UAE Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 65. Chile Pharmaceutical Serialisation Services Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Barcode
  • QR Code
  • RFID
  • Others
Applications
  • Pharmaceutical Manufacturing
  • Pharmaceutical Distribution
  • Pharmaceutical Logistics
Companies covered
  • Movianto
  • UPM Pharmaceuticals
  • MSK Pharmalogisti
  • Covectra
  • Koerber-Pharma
  • Palladio Group
  • TraceLink
  • Ultimate Solutions
  • Clarkston Consulting
  • Jones Healthcare Group
  • MSK Pharmalogistic
  • Vetter-Pharma
  • NextPharma Logistics
  • OPTEL
  • Central Pharma
  • Aphena Pharma +C581Solutions
  • NNE
  • Sharp Services

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pharmaceutical Serialisation Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Barcode
  5. 1.2.3 QR Code
  6. 1.2.4 RFID
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Pharmaceutical Serialisation Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical Manufacturing
  11. 1.3.3 Pharmaceutical Distribution
  12. 1.3.4 Pharmaceutical Logistics
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Pharmaceutical Serialisation Services Growth Trends by Region
  15. 1.5.1 Global Pharmaceutical Serialisation Services Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Pharmaceutical Serialisation Services Market Size by Region (2021-2026)
  17. 1.5.3 Pharmaceutical Serialisation Services Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Pharmaceutical Serialisation Services Market Dynamics
  1. 2.1 Pharmaceutical Serialisation Services Industry Trends
  2. 2.2 Pharmaceutical Serialisation Services Industry Drivers
  3. 2.3 Pharmaceutical Serialisation Services Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Serialisation Services Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pharmaceutical Serialisation Services Revenue by Company (2021-2026)
  2. 3.2 Global Pharmaceutical Serialisation Services Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pharmaceutical Serialisation Services Key Company Head office and Area Served
  4. 3.4 Global Pharmaceutical Serialisation Services Company, Product Type & Application
  5. 3.5 Global Pharmaceutical Serialisation Services Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pharmaceutical Serialisation Services Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pharmaceutical Serialisation Services Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pharmaceutical Serialisation Services Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Serialisation Services Market by Type
  1. 4.1 Global Pharmaceutical Serialisation Services Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pharmaceutical Serialisation Services Market Size by Type (2021-2032)
  3. 4.3 Global Pharmaceutical Serialisation Services Market Size Share by Type (2021-2032)
5 Pharmaceutical Serialisation Services Market by Application
  1. 5.1 Global Pharmaceutical Serialisation Services Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical Serialisation Services Market Size by Application (2021-2032)
  3. 5.3 Global Pharmaceutical Serialisation Services Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Movianto
  2. 6.1.1 Movianto Company Information
  3. 6.1.2 Movianto Business Overview
  4. 6.1.3 Movianto Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Movianto Pharmaceutical Serialisation Services Product Portfolio
  6. 6.1.5 Movianto Recent Developments
  7. 6.2 UPM Pharmaceuticals
  8. 6.2.1 UPM Pharmaceuticals Company Information
  9. 6.2.2 UPM Pharmaceuticals Business Overview
  10. 6.2.3 UPM Pharmaceuticals Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 UPM Pharmaceuticals Pharmaceutical Serialisation Services Product Portfolio
  12. 6.2.5 UPM Pharmaceuticals Recent Developments
  13. 6.3 MSK Pharmalogisti
  14. 6.3.1 MSK Pharmalogisti Company Information
  15. 6.3.2 MSK Pharmalogisti Business Overview
  16. 6.3.3 MSK Pharmalogisti Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 MSK Pharmalogisti Pharmaceutical Serialisation Services Product Portfolio
  18. 6.3.5 MSK Pharmalogisti Recent Developments
  19. 6.4 Covectra
  20. 6.4.1 Covectra Company Information
  21. 6.4.2 Covectra Business Overview
  22. 6.4.3 Covectra Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Covectra Pharmaceutical Serialisation Services Product Portfolio
  24. 6.4.5 Covectra Recent Developments
  25. 6.5 Koerber-Pharma
  26. 6.5.1 Koerber-Pharma Company Information
  27. 6.5.2 Koerber-Pharma Business Overview
  28. 6.5.3 Koerber-Pharma Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Koerber-Pharma Pharmaceutical Serialisation Services Product Portfolio
  30. 6.5.5 Koerber-Pharma Recent Developments
  31. 6.6 Palladio Group
  32. 6.6.1 Palladio Group Company Information
  33. 6.6.2 Palladio Group Business Overview
  34. 6.6.3 Palladio Group Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Palladio Group Pharmaceutical Serialisation Services Product Portfolio
  36. 6.6.5 Palladio Group Recent Developments
  37. 6.7 TraceLink
  38. 6.7.1 TraceLink Company Information
  39. 6.7.2 TraceLink Business Overview
  40. 6.7.3 TraceLink Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 TraceLink Pharmaceutical Serialisation Services Product Portfolio
  42. 6.7.5 TraceLink Recent Developments
  43. 6.8 Ultimate Solutions
  44. 6.8.1 Ultimate Solutions Company Information
  45. 6.8.2 Ultimate Solutions Business Overview
  46. 6.8.3 Ultimate Solutions Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Ultimate Solutions Pharmaceutical Serialisation Services Product Portfolio
  48. 6.8.5 Ultimate Solutions Recent Developments
  49. 6.9 Clarkston Consulting
  50. 6.9.1 Clarkston Consulting Company Information
  51. 6.9.2 Clarkston Consulting Business Overview
  52. 6.9.3 Clarkston Consulting Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Clarkston Consulting Pharmaceutical Serialisation Services Product Portfolio
  54. 6.9.5 Clarkston Consulting Recent Developments
  55. 6.10 Jones Healthcare Group
  56. 6.10.1 Jones Healthcare Group Company Information
  57. 6.10.2 Jones Healthcare Group Business Overview
  58. 6.10.3 Jones Healthcare Group Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Jones Healthcare Group Pharmaceutical Serialisation Services Product Portfolio
  60. 6.10.5 Jones Healthcare Group Recent Developments
  61. 6.11 MSK Pharmalogistic
  62. 6.11.1 MSK Pharmalogistic Company Information
  63. 6.11.2 MSK Pharmalogistic Business Overview
  64. 6.11.3 MSK Pharmalogistic Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 MSK Pharmalogistic Pharmaceutical Serialisation Services Product Portfolio
  66. 6.11.5 MSK Pharmalogistic Recent Developments
  67. 6.12 Vetter-Pharma
  68. 6.12.1 Vetter-Pharma Company Information
  69. 6.12.2 Vetter-Pharma Business Overview
  70. 6.12.3 Vetter-Pharma Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Vetter-Pharma Pharmaceutical Serialisation Services Product Portfolio
  72. 6.12.5 Vetter-Pharma Recent Developments
  73. 6.13 NextPharma Logistics
  74. 6.13.1 NextPharma Logistics Company Information
  75. 6.13.2 NextPharma Logistics Business Overview
  76. 6.13.3 NextPharma Logistics Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 NextPharma Logistics Pharmaceutical Serialisation Services Product Portfolio
  78. 6.13.5 NextPharma Logistics Recent Developments
  79. 6.14 OPTEL
  80. 6.14.1 OPTEL Company Information
  81. 6.14.2 OPTEL Business Overview
  82. 6.14.3 OPTEL Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 OPTEL Pharmaceutical Serialisation Services Product Portfolio
  84. 6.14.5 OPTEL Recent Developments
  85. 6.15 Central Pharma
  86. 6.15.1 Central Pharma Company Information
  87. 6.15.2 Central Pharma Business Overview
  88. 6.15.3 Central Pharma Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Central Pharma Pharmaceutical Serialisation Services Product Portfolio
  90. 6.15.5 Central Pharma Recent Developments
  91. 6.16 Aphena Pharma +C581Solutions
  92. 6.16.1 Aphena Pharma +C581Solutions Company Information
  93. 6.16.2 Aphena Pharma +C581Solutions Business Overview
  94. 6.16.3 Aphena Pharma +C581Solutions Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Aphena Pharma +C581Solutions Pharmaceutical Serialisation Services Product Portfolio
  96. 6.16.5 Aphena Pharma +C581Solutions Recent Developments
  97. 6.17 NNE
  98. 6.17.1 NNE Company Information
  99. 6.17.2 NNE Business Overview
  100. 6.17.3 NNE Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 NNE Pharmaceutical Serialisation Services Product Portfolio
  102. 6.17.5 NNE Recent Developments
  103. 6.18 Sharp Services
  104. 6.18.1 Sharp Services Company Information
  105. 6.18.2 Sharp Services Business Overview
  106. 6.18.3 Sharp Services Pharmaceutical Serialisation Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Sharp Services Pharmaceutical Serialisation Services Product Portfolio
  108. 6.18.5 Sharp Services Recent Developments
7 North America
  1. 7.1 North America Pharmaceutical Serialisation Services Market Size (2021-2032)
  2. 7.2 North America Pharmaceutical Serialisation Services Market Size by Type
  3. 7.2.1 North America Pharmaceutical Serialisation Services Market Size by Type (2021-2026)
  4. 7.2.2 North America Pharmaceutical Serialisation Services Market Size by Type (2027-2032)
  5. 7.2.3 North America Pharmaceutical Serialisation Services Market Share by Type (2021-2032)
  6. 7.3 North America Pharmaceutical Serialisation Services Market Size by Application
  7. 7.3.1 North America Pharmaceutical Serialisation Services Market Size by Application (2021-2026)
  8. 7.3.2 North America Pharmaceutical Serialisation Services Market Size by Application (2027-2032)
  9. 7.3.3 North America Pharmaceutical Serialisation Services Market Share by Application (2021-2032)
  10. 7.4 North America Pharmaceutical Serialisation Services Market Size by Country
  11. 7.4.1 North America Pharmaceutical Serialisation Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pharmaceutical Serialisation Services Market Size by Country (2021-2026)
  13. 7.4.3 North America Pharmaceutical Serialisation Services Market Size by Country (2027-2032)
  14. 7.4.4 North America Pharmaceutical Serialisation Services Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pharmaceutical Serialisation Services Market Size (2021-2032)
  2. 8.2 Europe Pharmaceutical Serialisation Services Market Size by Type
  3. 8.2.1 Europe Pharmaceutical Serialisation Services Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pharmaceutical Serialisation Services Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pharmaceutical Serialisation Services Market Share by Type (2021-2032)
  6. 8.3 Europe Pharmaceutical Serialisation Services Market Size by Application
  7. 8.3.1 Europe Pharmaceutical Serialisation Services Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pharmaceutical Serialisation Services Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pharmaceutical Serialisation Services Market Share by Application (2021-2032)
  10. 8.4 Europe Pharmaceutical Serialisation Services Market Size by Country
  11. 8.4.1 Europe Pharmaceutical Serialisation Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pharmaceutical Serialisation Services Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pharmaceutical Serialisation Services Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pharmaceutical Serialisation Services Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pharmaceutical Serialisation Services Market Size (2021-2032)
  2. 9.2 China Pharmaceutical Serialisation Services Market Size by Type
  3. 9.2.1 China Pharmaceutical Serialisation Services Market Size by Type (2021-2026)
  4. 9.2.2 China Pharmaceutical Serialisation Services Market Size by Type (2027-2032)
  5. 9.2.3 China Pharmaceutical Serialisation Services Market Share by Type (2021-2032)
  6. 9.3 China Pharmaceutical Serialisation Services Market Size by Application
  7. 9.3.1 China Pharmaceutical Serialisation Services Market Size by Application (2021-2026)
  8. 9.3.2 China Pharmaceutical Serialisation Services Market Size by Application (2027-2032)
  9. 9.3.3 China Pharmaceutical Serialisation Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pharmaceutical Serialisation Services Market Size (2021-2032)
  2. 10.2 Asia Pharmaceutical Serialisation Services Market Size by Type
  3. 10.2.1 Asia Pharmaceutical Serialisation Services Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pharmaceutical Serialisation Services Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pharmaceutical Serialisation Services Market Share by Type (2021-2032)
  6. 10.3 Asia Pharmaceutical Serialisation Services Market Size by Application
  7. 10.3.1 Asia Pharmaceutical Serialisation Services Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pharmaceutical Serialisation Services Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pharmaceutical Serialisation Services Market Share by Application (2021-2032)
  10. 10.4 Asia Pharmaceutical Serialisation Services Market Size by Country
  11. 10.4.1 Asia Pharmaceutical Serialisation Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pharmaceutical Serialisation Services Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pharmaceutical Serialisation Services Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pharmaceutical Serialisation Services Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pharmaceutical Serialisation Services Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pharmaceutical Serialisation Services Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pharmaceutical Serialisation Services Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pharmaceutical Serialisation Services Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pharmaceutical Serialisation Services Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pharmaceutical Serialisation Services Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pharmaceutical Serialisation Services Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pharmaceutical Serialisation Services Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pharmaceutical Serialisation Services Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pharmaceutical Serialisation Services Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pharmaceutical Serialisation Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pharmaceutical Serialisation Services Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pharmaceutical Serialisation Services Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pharmaceutical Serialisation Services Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst